Insights

Strong Financial Backing Ultragenyx secured $400 million in recent funding, highlighting their capacity for large-scale clinical development and commercialization efforts. This financial stability presents opportunities to offer specialized services, partnerships, or technology solutions to support their expanding portfolio.

Focus on Rare Diseases With a clear mission to address high unmet medical needs in rare and ultra-rare genetic disorders, Ultragenyx continuously seeks innovative therapies. There is potential to introduce specialized research tools, delivery technologies, or companion diagnostics tailored to their therapeutic pipeline.

Market Growth Potential Ultragenyx is advancing therapies for conditions such as Angelman Syndrome and rare genetic disorders, with designations like Breakthrough Therapy. Market entry strategies for related medical devices, diagnostics, or patient support solutions could align well with their development trajectory.

Innovation and Pipelines The company maintains a diverse and robust pipeline, including oligonucleotide therapies and novel drug candidates. Opportunities exist for collaboration on cutting-edge research, clinical trial support, or manufacturing services focusing on advanced biotech formats.

Global Recognition & Culture Recognized as a Top Workplace, Ultragenyx demonstrates strong engagement and a growth-oriented culture. Engaging with their team through talent solutions, training platforms, or employee-centric technologies can facilitate strategic partnerships and support their innovative environment.

Ultragenyx Tech Stack

Ultragenyx uses 8 technology products and services including Adobe, Power BI, SAP Crystal Solutions, and more. Explore Ultragenyx's tech stack below.

  • Adobe
    Audio, Video, Graphics
  • Power BI
    Business Intelligence
  • SAP Crystal Solutions
    Business Intelligence
  • Amazon Web Services
    Cloud Hosting
  • Microsoft Outlook
    Email
  • Oracle E-Business Suite
    Enterprise Resource Planning
  • SailPoint
    Identity And Access Management
  • Cisco
    Network Hardware

Media & News

Ultragenyx's Email Address Formats

Ultragenyx uses at least 1 format(s):
Ultragenyx Email FormatsExamplePercentage
FLast@ultragenyx.comJDoe@ultragenyx.com
94%
FiLast@ultragenyx.comJoDoe@ultragenyx.com
4%
LFirst@ultragenyx.comDJohn@ultragenyx.com
1%
FirstLast@ultragenyx.comJohnDoe@ultragenyx.com
1%

Frequently Asked Questions

Where is Ultragenyx's headquarters located?

Minus sign iconPlus sign icon
Ultragenyx's main headquarters is located at 60 Leveroni Court Novato, California 94949 United States. The company has employees across 5 continents, including North AmericaEuropeSouth America.

What is Ultragenyx's phone number?

Minus sign iconPlus sign icon
You can contact Ultragenyx's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ultragenyx's stock symbol?

Minus sign iconPlus sign icon
Ultragenyx is a publicly traded company; the company's stock symbol is RARE.

What is Ultragenyx's official website and social media links?

Minus sign iconPlus sign icon
Ultragenyx's official website is ultragenyx.com and has social profiles on LinkedIn.

What is Ultragenyx's SIC code NAICS code?

Minus sign iconPlus sign icon
Ultragenyx's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ultragenyx have currently?

Minus sign iconPlus sign icon
As of February 2026, Ultragenyx has approximately 1.6K employees across 5 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: J. R.Chief Medical Officer And Executive Vice President: E. C.Chief Accounting Officer (cao), Svp: T. H.. Explore Ultragenyx's employee directory with LeadIQ.

What industry does Ultragenyx belong to?

Minus sign iconPlus sign icon
Ultragenyx operates in the Biotechnology Research industry.

What technology does Ultragenyx use?

Minus sign iconPlus sign icon
Ultragenyx's tech stack includes AdobePower BISAP Crystal SolutionsAmazon Web ServicesMicrosoft OutlookOracle E-Business SuiteSailPointCisco.

What is Ultragenyx's email format?

Minus sign iconPlus sign icon
Ultragenyx's email format typically follows the pattern of FLast@ultragenyx.com. Find more Ultragenyx email formats with LeadIQ.

When was Ultragenyx founded?

Minus sign iconPlus sign icon
Ultragenyx was founded in 2010.

Ultragenyx

Biotechnology ResearchCalifornia, United States1001-5000 Employees

Leading with purpose. Every day.

“Ultragenyx was founded to advance innovative medicines for rare and ultrarare diseases that have never been treated before. We are delivering transformative therapies across multiple indications, and we have one of the most robust and diverse clinical pipelines in rare disease. Our focus is on doing the right things for patients both during development and commercialization to deliver on the promise of these therapies in a way that's meaningful for rare disease communities.”

Emil D. Kakkis, M.D., Ph.D.
Chief Executive Officer and President


We have an inclusive culture of value and respect.

Ultragenyx brings novel products to those living with rare and ultrarare diseases with a focus on debilitating genetic diseases. Founded in 2010, we have rapidly built a diverse portfolio of approved therapies and products aimed at diseases with a high unmet medical need for which many have no approved therapies. It takes courage, care, talent, and dedication to make a meaningful impact for those living with rare diseases, their families and the rare disease community.  

We put our people first, so they can take care of the rare disease community.

We purposefully cultivate and nurture a dynamic, supportive work environment where we encourage every team member to share their new ideas and help us unlock more possibilities. Our team is made up of exceptional and diverse people with a strong passion and commitment to helping those living with rare diseases. By embracing generosity, curiosity, inclusion, and humility we are constantly learning together—fostering an environment that supports profound growth and fulfillment.

If you want to have a meaningful impact, do the best work of your career while having fun and growing professionally and personally, come join our team!


Visit our community guidelines at: https://ultragenyx.co/community

Section iconCompany Overview

Headquarters
60 Leveroni Court Novato, California 94949 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
RARE
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
1001-5000

Section iconFunding & Financials

  • $250M$500M

    Ultragenyx's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $250M$500M

    Ultragenyx's revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.